Northwestern Medicine scientists have uncovered how a major Parkinson's disease gene disrupts the brain's most vulnerable ...
Four-part digital program addressing Parkinson’s disease through dopamine support, neuroinflammation reduction, gentle ...
Parkinson’s disease is the fastest-growing neurological disorder globally, with numbers predicted to rise rapidly. Can these ...
As Parkinson's disease increasingly affects younger Nigerians, the Adewunmi Desalu Parkinson's Foundation (ADPF) has urged federal and state governments ...
Clinical Trials Arena on MSN
ABLI reports biomarker findings from risvodetinib study for Parkinson’s
The findings suggest that once-daily risvodetinib impacts several biological processes associated with Parkinson’s disease.
PD respond in concert to risvodetinib treatment in patients with early untreated Parkinson’s diseaseATLANTA and BOSTON, Aug.
In parallel, Lunai's wholly owned subsidiary BioSymetrics Inc. ("BioSymetrics"), published a new technical white paper, Phenoclustering Parkinson's Disease to Uncover New Targets and Biomarkers. The ...
Investigators Present Data Supporting Disease-Modifying Potential of the Io Therapeutics RXR Agonist Compound IRX4204 in Parkinson’s Disease ...
A new study from Reichman University has found that a short, three-week digital training program, combined with standard drug ...
Long-term exposure to road traffic noise can do more to your health than just disturb your sleep. It can increase the risk of ...
Glucagon-like peptide-1 receptor agonists are associated with increased gastrointestinal adverse events and no symptom relief ...
Scientists are studying how the nervous system synchronizes with rhythm and sound, opening new possibilities for neurological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results